DexCom
DXCM
939 hedge funds and large institutions have $31.9B invested in DexCom in 2025 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 340 increasing their positions, 349 reducing their positions, and 105 closing their positions.
29% more capital invested
Capital invested by funds: $24.8B → $31.9B (+$7.08B)
17% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 105
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
1% more funds holding
Funds holding: 932 → 939 (+7)
0.08% more ownership
Funds ownership: 93.29% → 93.37% (+0.08%)
3% less repeat investments, than reductions
Existing positions increased: 340 | Existing positions reduced: 349
6% less call options, than puts
Call options by funds: $490M | Put options by funds: $519M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$267M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$217M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$198M |
| 4 |
JP Morgan Chase
New York
|
+$158M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$520M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$132M |
| 3 |
Amundi
Paris,
France
|
-$88.4M |
| 4 |
D.E. Shaw & Co
New York
|
-$87.8M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$77.8M |
DXCM Hedge Fund Activity: Q2 2025 in Review
939 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2025, worth a combined $31.9B — up 29% from $24.8B a quarter earlier.
Buyers outnumbered sellers: 123 funds opened new DXCM positions and 105 closed out — a net gain of 18 holders — while 340 added to existing stakes and 349 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $267M. The largest seller was Capital Research Global Investors, cutting an estimated $520M.
- 939 institutional investors held DexCom (DXCM) as of Q2 2025, up from 932 in Q1 2025.
- Funds reported $31.9B of DexCom stock for Q2 2025, up 29% quarter-over-quarter.
- 123 funds opened new DexCom positions in Q2 2025 and 105 closed out, a net change of +18 holders.
- The largest DexCom buyer in Q2 2025 was Massachusetts Financial Services, an estimated $267M added.
- The largest DexCom seller in Q2 2025 was Capital Research Global Investors, an estimated $520M sold.
Based on aggregated 13F filings for Q2 2025.